This site is intended for health professionals only

Third-phase success for RA drug

teaser

Roche has presented yet more positive data from the third late-stage study of its experimental compound for rheumatoid arthritis, Actemra






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x